Cancer Research UK, and the KWF Dutch Cancer Society (KWF), two of the world’s largest charitable funders of cancer research, announce a new multi-project strategic partnership to advance promising therapeutic agents for cancer through early clinical development.
07 November, 2023
Researchers have built the first ever map showing how every single neuron in the nervous system of a tiny worm communicates wirelessly
07 November, 2023
The trial showed that KT-110 has superior efficacy in reducing alcohol consumption. KT-110 will be deliverable in a once-daily tablet (proprietary formulation). KT-110’s mode of action is novel to Alcohol Use Disorder (AUD) and works by simultaneously modulating the noradrenergic and serotonergic brain receptors that counteract the neurobiological processes involved in addictionAlcohol dependence, or AUD, is a serious public health issue and the medical need for the treatment of alcoholism is considerable and unmet. Kinnov Therapeutics expects to have clear guidance from the FDA in early 2024 on the phase III trial
07 November, 2023
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
07 November, 2023
Bio-IT World Conference & Expo to Foster Collaboration Among Life Sciences, IT and Healthcare Leaders Who are Redefining Precision Medicine
07 November, 2023
Pharma Integrates, 16 November 2023, The Mermaid, London
02 November, 2023
Over two million doses of illegally traded medicines valued at almost £5m seized so far this year.
02 November, 2023
Investors need confidence and predictability if they are to invest in the fight against antibiotic resistance, finds a new report.
02 November, 2023